Proposal software for CROs & life-sciences services firms

Proposal software for CROs and life-sciences services firms is purpose-built for the way these firms actually sell: into federal health buyers like NIH, FDA, CDC, CMS, and BARDA, across distinct service lines, with intelligence that understands clinical and research work. VoXorian discovers those opportunities, ranks them by semantic fit to your service lines, and drafts proposals tuned to the domain — instead of treating a clinical-trials RFP like any other document.

Why CROs have distinct proposal needs

A contract research organization or life-sciences services firm doesn't bid the way a general IT contractor does. The buyers are specialized — NIH institutes, FDA, CDC, CMS, BARDA, and academic medical centers — and each evaluates work against deep domain expectations. The offerings are organized into service lines that a generic proposal tool has no concept of:

• Biostatistics and statistical programming
• Clinical operations and trial management
• Health economics and outcomes research (HEOR) and real-world evidence (RWE)
• Pharmacovigilance and safety
• Medical writing and regulatory documentation

A win in one service line says little about fit in another. Generic government-proposal software treats every opportunity as interchangeable; a firm with strong biostatistics depth but no pharmacovigilance practice needs tooling that can tell the difference.

Opportunity discovery and semantic fit to your service lines

The first job is surfacing the right opportunities. VoXorian discovers federal opportunities and ranks each one by semantic fit — comparing the actual language of the solicitation against the service lines you've configured, so a clinical-operations RFP scores against your clinical-operations capability rather than your overall company profile.

Crucially, fit is a signal, not a gate. A low fit score never hides an opportunity or makes a decision for you; it informs your team's go/no-go judgment. You stay in control of what you pursue, and the score simply helps you triage a long list faster. This is the same discipline that powers VoXorian's broader market intelligence.

NIH funded-research signals

For health and research markets, some of the best early signals don't come from solicitation feeds at all — they come from who is already funded. VoXorian scans NIH-funded research to surface recompete and teaming signals: awards ending soon that may lead to a follow-on, and funded projects whose principal investigators or institutions are natural teaming partners.

An NIH award ending soon becomes your next opening — a way to start capture before a formal opportunity exists. If you want the full playbook for working expiring awards, see recompete intelligence.

Capture and one-click drafting, tuned to the domain

Once an opportunity is worth pursuing, the same thread carries through capture and drafting. VoXorian offers suggestion packs — domain-aware prompts and content suggestions oriented to life-sciences work — so the system speaks your vocabulary rather than generic government boilerplate. When the RFP is in hand, one-click drafting builds the proposal section by section from your approved library content, grounded and cited for human review.

Because the platform understands your service lines from discovery through drafting, the biostatistics narrative reads like biostatistics and the HEOR section reads like HEOR — without re-keying your capabilities for every bid. For more on AI-assisted responses generally, see AI RFP response.

Frequently asked questions

Which buyers does VoXorian support for life sciences? The platform is tuned to federal health buyers — NIH institutes, FDA, CDC, CMS, and BARDA — as well as academic medical centers, with intelligence drawn from public sources including NIH funded-research data.

Does a low fit score block an opportunity? No. Fit is a signal, never a gate. The score helps your team triage and prioritize, but you decide what to pursue and nothing is hidden from you.

Can it handle multiple service lines? Yes. You configure your service lines — biostatistics, clinical operations, HEOR/RWE, pharmacovigilance, medical writing — and opportunities are scored against each, so cross-discipline firms see fit per capability.